Genome-wide analysis of oral cancer--early results from the Cancer Genome Anatomy Project.

The Cancer Genome Anatomy Project (CGAP) is a large cooperative effort sponsored by the US National Institutes of Health designed to find, catalog and annotate genes that are expressed during cancer development. In the past 2 years, the CGAP has sequenced over 700,000 clones from approximately 140 cDNA libraries, resulting in the identification of over 30,000 new human genes. As a first step in applying this project to oral cancer we entered four cell lines--two from oral cancer, one from primary oral keratinocytes, and one from oral keratinocytes which had been immortalized by human papillomavirus. Libraries of cDNA were made and sequenced and the data were deposited in GenBank. The expressed genes were then identified where possible. The cell lines, and the total number of expressed genes that were cloned from each were: HN3 (oral cancer), 263 genes; HN4 (oral cancer), 550 genes; HN5 (primary keratinocytes), 237 genes; HN6 (immortalized keratinocytes), 408 genes. The total number of different genes that were found was 1160. A total of 38 new genes, of unknown function, were discovered. The data presented here represent a beginning of the application of the CGAP technology to oral cancer. Even though the data are still quite incomplete, they already represent a large quantity of new information and clones of potential utility to the oral cancer community, and provide a glimpse of the data sets to be forthcoming from the Project. It must therefore be expected that there will soon be a large expansion in the volume of data regarding the genetics of oral cancer. Those who study this disease must be prepared to develop new methods of analysis and storage for handling the oncoming volumes of information.

[1]  N. Park,et al.  Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes , 1999, Oncogene.

[2]  J. Papadimitriou,et al.  Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. , 1997, Cancer detection and prevention.

[3]  J. Yook,et al.  Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. , 1998, Oral oncology.

[4]  W. A. Yeudall,et al.  Altered expression and activity of G1/S cyclins and cyclin‐dependent kinases characterize squamous cell carcinomas of the head and neck , 1997, International journal of cancer.

[5]  P. Sugerman,et al.  The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. , 2008, Oral diseases.

[6]  R. Fleischmann,et al.  Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. , 1995, Nature.

[7]  G. Milo,et al.  Keratin 19 Downregulation by Oral Squamous Cell Carcinoma Lines Increases Invasive Potential , 1999, Journal of dental research.

[8]  G. Schuler Pieces of the puzzle: expressed sequence tags and the catalog of human genes , 1997, Journal of Molecular Medicine.

[9]  A. Yung,et al.  Differential expression of epidermal growth factor receptor in human head and neck cancers , 1998, Head & neck.

[10]  D. Wong TGF-α and oral carcinogenesis , 1993 .

[11]  Carol A. Dahl,et al.  New opportunities for uncovering the molecular basis of cancer , 1997, Nature Genetics.

[12]  J. Ensley,et al.  Tyrosine phosphorylation as a marker for aberrantly regulated growth‐promoting pathways in cell lines derived from head and neck malignancies , 1995, International journal of cancer.

[13]  I. Pastan,et al.  PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[15]  Arlene A. Forastiere,et al.  Head and Neck , 1998, Indian Journal of Radiology and Imaging.

[16]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[17]  S. Nelson,et al.  Characterization of transformation related genes in oral cancer cells , 1998, Oncogene.

[18]  K. Fu,et al.  Apoptosis-associated proteins and the development of oral squamous cell carcinoma. , 1999, Oral oncology.

[19]  M. Spitz,et al.  Alterations of p53, cyclin D1, rb, and H‐ras in human oral carcinomas related to tobacco use , 1998, Cancer.

[20]  M. Hung,et al.  Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  B. Têtu,et al.  p53 overexpression in head and neck squamous cell carcinoma: review of the literature. , 1996, European journal of cancer. Part B, Oral oncology.

[22]  J Zhang,et al.  Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma. , 1997, Clinical and experimental immunology.

[23]  J. Eveson,et al.  Molecular changes in oral cancer may reflect aetiology and ethnic origin. , 1996, European journal of cancer. Part B, Oral oncology.

[24]  E Pennisi,et al.  Academic Sequencers Challenge Celera in a Sprint to the Finish , 1999, Science.

[25]  J. Willey,et al.  Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. , 1998, American journal of respiratory cell and molecular biology.

[26]  P. Speight,et al.  Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. , 1996, European journal of cancer. Part B, Oral oncology.